Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer-Reference-Cited by-同舟云学术

Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer

Published:2021-04 Issue: Volume:62 Page:102405
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Fulfager Aditi D.,Yadav Khushwant S.^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference119 articles.

1. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer;Yuan;Drug Deliv.,2016

2. Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy;Fang;J. Drug Deliv. Sci. Technol.,2020

3. Understanding Breast cancer: from conventional therapies to repurposed drugs;Costa;Eur. J. Pharmacol.,2020

4. Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies;Nounou;Breast Cancer,2015

5. Classification, treatment strategy, and associated drug resistance in breast cancer;Tang;Clin. Breast Canc.,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hollow MIL-125 Nanoparticles Loading Doxorubicin Prodrug and 3-Methyladenine for Reversal of Tumor Multidrug Resistance;Journal of Functional Biomaterials;2023-11-13

2. Benefits of using polymeric nanoparticles in breast cancer treatment: a systematic review;3 Biotech;2023-10-08

3. Anticancer and apoptosis inducing potential of quercetin against a wide range of human malignancies;International Journal of Food Properties;2023-09-07

4. Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells;Journal of Drug Delivery Science and Technology;2023-09

5. Current Perspectives on Nanoparticle-based Targeted Drug Delivery Approaches in Breast Cancer Treatment;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-09